Welcome to our dedicated page for Epsium Enterprise Ltd. news (Ticker: EPSM), a resource for investors and traders seeking the latest updates and insights on Epsium Enterprise Ltd. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Epsium Enterprise Ltd.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Epsium Enterprise Ltd.'s position in the market.
EPSIUM ENTERPRISE (Nasdaq: EPSM) has successfully completed its Initial Public Offering (IPO) of 1,250,000 ordinary shares at $4.00 per share, raising gross proceeds of $5.0 million. The company's shares began trading on the Nasdaq Capital Market on March 26, 2025, under the ticker 'EPSM'.
The Macau-based alcoholic beverages importer and wholesaler plans to allocate the net proceeds as follows:
- 60% for acquisitions and investments in complementary assets
- 20% for general corporate purposes
- 10% for sales, product innovation, and brand building
- 10% as reserve subject to board discretion
The underwriters have a 45-day option to purchase up to an additional 187,500 ordinary shares. D. Boral Capital served as the sole underwriter for this firm commitment offering.
EPSIUM ENTERPRISE , a Macau-based alcoholic beverages importer and wholesaler, has announced the pricing of its Initial Public Offering (IPO) on the Nasdaq Capital Market under the symbol EPSM.
The company is offering 1,250,000 ordinary shares at $4.00 per share, aiming to raise $5.0 million in gross proceeds. Trading is expected to commence on March 26, 2025, with the offering closing around March 27, 2025. Underwriters have a 45-day option to purchase up to 187,500 additional shares.
The net proceeds allocation includes:
- 60% for acquisitions and investments in complementary businesses
- 20% for general corporate purposes
- 10% for sales, product innovation, and brand building
- 10% as reserve subject to board discretion
